A federal appeals court has rejected a bid by the widow of a Reed Smith partner who killed himself while taking a generic version of GlaxoSmithKline’s antidepressant Paxil to restore a $3 million verdict against the maker of the branded drug.
The 7th U.S. Circuit Court of Appeals in Chicago on Friday held that a recent U.S. Supreme Court ruling clarifying a key standard for drug-labeling disputes would not have altered its earlier decision in Wendy Dolin’s case to overturn the verdict.
o read the full story on Westlaw Practitioner Insights, click here: bit.ly/2Q08xnu
Our Standards: The Thomson Reuters Trust Principles.